Colorectal Cancer

Showing NaN - NaN of 117

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Colorectal Cancer Screening in Cystic Fibrosis

Recruiting
  • Cystic Fibrosis
  • +2 more
  • Stool tests
  • Los Angeles, California
  • +24 more
Jan 26, 2023

Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +38 more
Jan 25, 2023

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

Recruiting
  • Colorectal Cancer
  • +4 more
  • NUC-3373 + leucovorin
  • +8 more
  • Boston, Massachusetts
  • +9 more
Jan 23, 2023

Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +8 more
  • XmAb®808
  • Keytruda® (pembrolizumab)
  • Denver, Colorado
  • +2 more
Jan 19, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Tumors, Colorectal Cancer Trial in Grand Rapids, Nashville, Kirkland (MK-8353, Pembrolizumab)

Completed
  • Neoplasms
  • Colorectal Cancer
  • Grand Rapids, Michigan
  • +2 more
Dec 21, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

    Active, not recruiting
    • Hepatocellular Carcinoma
    • +11 more
    • Part 1 TPST-1120
    • +3 more
    • San Francisco, California
    • +10 more
    Nov 1, 2022

    Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,

    Active, not recruiting
    • Castration-resistant Prostate Cancer
    • +2 more
    • Tucson, Arizona
    • +19 more
    Oct 18, 2022

    Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

    Recruiting
    • Breast Cancer
    • +15 more
    • ATRC-101
    • +2 more
    • Phoenix, Arizona
    • +10 more
    Sep 28, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

    Recruiting
    • Ovarian Cancer
    • +68 more
    • Phoenix, Arizona
    • +8 more
    Aug 18, 2022

    Colorectal Cancer Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Pembrolizumab/Favezelimab)

    Recruiting
    • Colorectal Cancer
    • Pembrolizumab
    • +4 more
    • Orange City, Florida
    • +54 more
    Aug 17, 2022

    Colorectal Cancer, Triple Negative Breast Cancer, Gastric Cancer Trial in United States (navicixizumab+paclitaxel,

    Recruiting
    • Colorectal Cancer
    • +3 more
    • navicixizumab+paclitaxel
    • +2 more
    • Hot Springs, Arkansas
    • +5 more
    Aug 9, 2022

    Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

    Not yet recruiting
    • Endometrial Cancer
    • +4 more
    • Datopotamab deruxtecan (Dato-DXd)
    • +8 more
    • Los Angeles, California
    • +52 more
    Aug 3, 2022

    Colorectal Cancer Trial in Australia, Spain, United States (BLYG8824A)

    Recruiting
    • Colorectal Cancer
    • Duarte, California
    • +5 more
    Aug 2, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,

    Recruiting
    • Mesothelioma
    • +14 more
    • TC-510
    • +2 more
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 14, 2022

    Tissue and Biological Fluid Samples From Patients and Healthy

    Recruiting
    • Colorectal Cancer
    • +4 more
    • protein analysis
    • +10 more
    • Nashville, Tennessee
    • +3 more
    Jul 7, 2022

    Inherited Cancer Syndrome, Prostate Cancer, Colorectal Cancer Trial in Nashville (Correlative Studies (Survey), Correlative

    Not yet recruiting
    • Inherited Cancer Syndrome
    • +4 more
    • Correlative Studies (Survey)
    • +4 more
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Jul 5, 2022